Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-18 Purchase |
2021-08-19 5:23 pm |
IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President |
20,000 | $13.99 | $279,790 | 20,000 (Direct) |
View |
| 2021-04-27 Purchase |
2021-04-29 9:10 pm |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
575,000 | $15 | $8,625,000 | 349,674 (Indirect) |
View |
| 2021-04-27 Purchase |
2021-04-29 8:51 pm |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner |
575,000 | $15 | $8,625,000 | 575,000 (Indirect) |
View |
| 2021-04-27 Purchase |
2021-04-29 7:45 pm |
IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner |
825,000 | $15 | $12,375,000 | 3,077,198 (Direct) |
View |
| 2021-04-27 Purchase |
2021-04-29 6:44 pm |
IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
450,000 | $15 | $6,750,000 | 2,759,791 (Direct) |
View |
| 2021-04-27 Purchase |
2021-04-29 5:07 pm |
IMPEL NEUROPHARMA INC | IMPL | KKR Iris Investors LLC KKR Healthcare Strategic Growth Fund L.P. KKR Associates HCSG L.P. KKR HCSG GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
1,100,000 | $15 | $16,500,000 | 3,921,350 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-21 Exercise |
2021-09-22 4:57 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer |
53,954 | $2.95 | 103,512 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:57 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer |
14,780 | $1.97 | 103,512 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:57 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer |
4,650 | $2.46 | 103,512 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:57 pm |
N/A 2027-10-17 |
IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer |
73,384 | $0 | 103,512 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-26 6:04 pm |
N/A 2031-07-19 |
IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-26 6:02 pm |
N/A 2031-07-19 |
IMPEL NEUROPHARMA INC | IMPL | Paolillo Leonard Chief Commercial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-26 6:00 pm |
N/A 2031-07-19 |
IMPEL NEUROPHARMA INC | IMPL | Leaman John Harold Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-26 5:58 pm |
N/A 2031-07-19 |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-26 5:58 pm |
N/A 2031-07-19 |
IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-11 Option Award |
2021-07-13 5:12 pm |
N/A 2031-07-10 |
IMPEL NEUROPHARMA INC | IMPL | Wilfong Diane E. Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-07-11 Option Award |
2021-07-13 5:10 pm |
N/A 2031-07-10 |
IMPEL NEUROPHARMA INC | IMPL | SHAH MAHENDRA Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-07-11 Option Award |
2021-07-13 5:09 pm |
N/A 2031-07-10 |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-07-11 Option Award |
2021-07-13 5:06 pm |
N/A 2031-07-10 |
IMPEL NEUROPHARMA INC | IMPL | NELSON TIMOTHY S Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-07-11 Option Award |
2021-07-13 5:05 pm |
N/A 2031-07-10 |
IMPEL NEUROPHARMA INC | IMPL | Allison David D. Director |
11,500 | $0 | 11,500 (Direct) |
View |
Ownership(A) |
2021-06-22 5:41 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
0 | $0 | 16,148 (Direct) |
View |
| 2021-04-27 Conversion(A) |
2021-06-07 4:57 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
73,910 | $0 | 108,496 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 9:10 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
39,725,922 | $0 | 349,674 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-29 9:10 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
101,456 | $13.5 | 349,674 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-29 8:51 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner |
39,725,924 | $0 | 575,000 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-29 8:51 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner |
101,457 | $13.5 | 575,000 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-29 7:45 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner |
38,735,370 | $0 | 3,077,198 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 7:45 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner |
98,927 | $13.5 | 3,077,198 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 6:44 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
39,827,381 | $0 | 2,759,791 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 6:33 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
60,992 | $0 | 284,584 (Direct) |
View |
| 2021-04-27 Other |
2021-04-29 6:33 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
2,124 | $0 | 284,584 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 6:33 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
47,263 | $8.66 | 284,584 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 6:33 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
13,756 | $8.19 | 284,584 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 6:33 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
349,059 | $0 | 284,584 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 6:33 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
271 | $13.5 | 284,584 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 6:31 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
8,523 | $0 | 178,153 (Direct) |
View |
| 2021-04-27 Other |
2021-04-29 6:31 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
275 | $0 | 178,153 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 6:31 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
8,523 | $8.19 | 178,153 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 6:31 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
74,180 | $0 | 178,153 (Direct) |
View |
| 2021-04-27 Other |
2021-04-29 5:07 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | KKR Iris Investors LLC KKR Healthcare Strategic Growth Fund L.P. KKR Associates HCSG L.P. KKR HCSG GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
118,712 | $13.5 | 3,921,350 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-29 5:07 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | KKR Iris Investors LLC KKR Healthcare Strategic Growth Fund L.P. KKR Associates HCSG L.P. KKR HCSG GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
44,891,374 | $0 | 3,921,350 (Indirect) |
View |
| 2021-04-22 Other |
2021-04-26 7:11 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
1,359,799 | $0 | 1,359,799 (Direct) |
View |
| 2021-04-22 Other |
2021-04-26 7:02 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner |
1,325,893 | $0 | 1,325,893 (Direct) |
View |
| 2021-04-22 Other |
2021-04-26 6:24 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
1,359,799 | $0 | 1,359,799 (Indirect) |
View |
| 2021-04-22 Other |
2021-04-26 6:01 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
3,637 | $0 | 3,637 (Direct) |
View |
| 2021-04-22 Other |
2021-04-26 5:55 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
1,359,799 | $0 | 1,359,799 (Indirect) |
View |
Ownership |
2021-04-22 9:30 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,208,333 (Indirect) |
View |
Ownership |
2021-04-22 8:05 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
0 | $0 | 2,208,334 (Direct) |
View |
Ownership |
2021-04-22 8:04 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
0 | $0 | 2,208,334 (Indirect) |
View |
Ownership |
2021-04-22 7:55 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | KKR Iris Investors LLC KKR Healthcare Strategic Growth Fund L.P. KKR Associates HCSG L.P. KKR HCSG GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
0 | $0 | 2,583,926 (Indirect) |
View |
Ownership |
2021-04-22 7:29 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner |
0 | $0 | 2,153,271 (Direct) |
View |
Ownership |
2021-04-22 7:16 pm |
N/A 2029-11-20 |
IMPEL NEUROPHARMA INC | IMPL | Wilfong Diane E. Director |
0 | $0 | 31,356 (Direct) |
View |
Ownership |
2021-04-22 7:15 pm |
N/A 2027-02-13 |
IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer |
0 | $0 | 128,118 (Direct) |
View |
Ownership |
2021-04-22 7:14 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | SHAH MAHENDRA Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-04-22 7:12 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Satvat Ali J. Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-04-22 7:11 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | PARKER H STEWART Director |
0 | $0 | 152,016 (Direct) |
View |
Ownership |
2021-04-22 7:10 pm |
N/A 2031-03-17 |
IMPEL NEUROPHARMA INC | IMPL | Paolillo Leonard Chief Commercial Officer |
0 | $0 | 140,472 (Direct) |
View |
Ownership |
2021-04-22 7:10 pm |
N/A 2027-02-13 |
IMPEL NEUROPHARMA INC | IMPL | NELSON TIMOTHY S Director |
0 | $0 | 99,197 (Direct) |
View |
Ownership |
2021-04-22 7:06 pm |
N/A 2029-06-23 |
IMPEL NEUROPHARMA INC | IMPL | Leaman John Harold Chief Financial Officer |
0 | $0 | 256,549 (Direct) |
View |